
    
      Prospective, two arms, randomized multi-center trial in Asian-pacific region. Following
      angiography, patients with chronic total occlusion (more than 3 months) have documented
      myocardial ischemia or symptoms of angina, and eligible for stenting without any exclusion
      criteria will be randomized 1:1 to: a) drug-eluting stent vs. b) optimal medical treatment.
      All patients will be followed for at least 3 year.

      The subjects with chronic total occlusion but failed to random for any reason, they will be
      enrolled in registry group.

      The random design was closed at the date of 22 July 2019 however already randomized subjects
      and subjects from registry design continue 10 years follow-up on IRIS-CTO registry.
    
  